Resilience Continues Expansion With Acquisition Of Biologics Manufacturing Company Ology Bioservices
Click here to read the original article in San Francisco Business Times.
NEWS
Read on
How An East Bay Site May Lead A Biotech Manufacturing Revolution
The leaders of this startup, backed with $800 million and a facility in Fremont, believe they can spearhead manufacturing changes that will deliver...
With Stars Aligned And Cash In Reserve, Bob Nelsen’s Resilience Plans A Makeover At 2 New Facility Additions To Its Drug Manufacturing Upstart
Read on
Resilience Expands North American Capacity With The Acquisition Of Two Premier Biologics Manufacturing Facilities
Resilience announces the acquisition of two biologics manufacturing facilities in North America.
Fireside Chat With Rahul Signhvi, CEO Of Resilience
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member...
Resilience Bags Sanofi-Genzyme Plant In Boston
Newly formed CDMO Resilience takes over the once-troubled Allston facility in Massachusetts from Sanofi, retaining all 250 staff.
